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The composition of the atherosclerotic lesion rather than the degree of stenosis is currently
considered to be the most important determinant for acute clinical events. Modalities capable
of characterizing the atherosclerotic lesion may be helpful in understanding its natural history
and detecting lesions with high risk for acute events. Speaking grossly, three histologic
features of the vulnerable plaque have been reported: size of the atheroma, thickness of the
fibrous cap, and inflammation. Imaging techniques are currently being deployed and are
under development to aid visualization of the vulnerable coronary plaque. Most of these
diagnostic modalities have the potential to detect locally one or more of the three
histologically defined features of vulnerable plaque. This review will focus on imaging
techniques that have been developed to characterize the atherosclerotic lesion. Most
catheter-based visualization techniques will provide insight into components of the local
atherosclerotic plaque which may limit their predictive value for the occurrence of a clinical
event. Therefore, the clinical relevance of these imaging tools will be discussed. (J Am Coll
Cardiol 2000;36:13–21) © 2000 by the American College of Cardiology
An imaging modality that is designed to visualize the coronary
lumen is a diagnostic tool that depicts the outcome of athero-
sclerotic disease retrospectively. The percentage of luminal
narrowing is a surrogate diagnostic measure for atherosclerosis,
which itself is a disease of the arterial wall (1–4). Imaging
techniques that visualize the coronary lumen have a low
predictive value for the risk of acute occlusion (5–7).
The fine structure and composition of the atherosclerotic
lesion, rather than the degree of stenosis, are currently
considered to be the important determinants for acute
clinical events, together with the absence of collateral
circulation (1–4,9–12). Modalities capable of characterizing
the tissue of the atherosclerotic lesion may help to under-
stand its natural history and detect lesions with high risk for
acute events.
This review will focus on techniques currently deployed
and under development to visualize the vulnerable coronary
plaque according to histologic characteristics, or identify the
vulnerable plaque according to its chemical or physical
properties. In addition, the clinical relevance of these
imaging tools will be discussed.
THE VULNERABLE LESION:
STRUCTURE AND COMPOSITION
The typical advanced atherosclerotic lesion is characterized
by a core of extracellular lipid with an overlaying fibrous
collagen-rich cap (1). The lipid core may contain layers of
fibrous tissue. Atheromatous lesions with a sclerotic fibrous
cap may transform into a complex type of lesion by rupture
or erosion of the fibrous cap with subsequent formation of
a thrombus. The lesion that is rupture prone is not clearly
defined, but several morphologic and immunologic deter-
minants specific for the vulnerable plaque have been re-
ported (1–4,9–12). In order to evaluate the applicability of
imaging techniques that are potentially capable of predicting
which lesions may rupture, it is necessary to understand
what specific features of the vulnerable lesion each of these
techniques reveals. Grossly, there are three major, interre-
lated determinants of a plaque’s vulnerability to rupture.
Thickness of the fibrous cap. The cap overlying the
atheromatous core consists of extracellular collagen-rich
matrix and smooth muscle cells (Fig. 1). Fissures primarily
occur in eccentric lesions at the shoulder region of the cap
that is often thinnest with reduced collagen content (3). The
peak circumferential stress is inversely related to cap thick-
ness (13–15). When the fibrous cap is thin and a high
circumferential stress at the luminal border of the plaque is
present, plaque rupture is more likely to occur (16). Using
finite element analysis, Loree et al. (14) showed that
circumferential stress increases critically when cap thickness
is less than approximately 150 mm. Hemodynamically
related mechanical forces do not only directly induce plaque
thinning but they also trigger release and/or activation of
matrix degrading proteases (17) that degrade structural
components within the fibrous cap (18).
Size and composition of the atheromatous lipid core.
Plaques containing a highly thrombogenic lipid-rich core
are more at risk for rupture if the size of the lipid core is
large and is less consistent. Several investigators have
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reported on the relation of the amount of extracellular gruel
and plaque fissuring (8,19,20). Davies et al. (8) estimated
that when at least 40% of the plaque consists of lipid, an
atheroma is at risk for rupture.
The consistency of the lipid core depends on lipid
composition and temperature. A negative relation exists
between temperature and core stiffness (21,22). If temper-
ature increases, like with inflammation, the core becomes
softer. Another determinant of plaque consistency is the
composition of the atheroma: liquid cholesterol esters are
softer than crystalline cholesterol. A soft core may be more
vulnerable for rupture since it may not be able to bear the
imposed circumferential stress, which is then redistributed
to the fibrous cap where it may be critically concentrated
(16).
Inflammation within or adjacent to the fibrous cap.
Disruption of the fibrous cap is usually associated with
heavy local infiltration by macrophages and often by
T-lymphocytes. Activated macrophages are strongly co-
localized with local thrombi as observed in patients who
died of myocardial infarction (9). In addition, macrophages
are more frequently demonstrated in coronary artery speci-
mens obtained from patients suffering from unstable angina
compared with patients with stable coronary artery syn-
dromes (10).
Macrophages, but also other plaque-related cell types,
may release matrix degrading proteases, the matrix metal-
loproteinases (MMPs) (8,23). The most frequently investi-
gated MMPs with respect to plaque vulnerability (and
atherosclerotis in general) are the collagenase MMP-1, the
gelatinases MMP-2 and MMP-9 and stromelysin MMP-3.
Matrix metalloproteinase-1 is colocalized with regions of
high circumferential stresses, like the shoulders of an eccen-
tric plaque (17); MMP-2 and MMP-9 are often studied in
activity assays, zymography, and are associated with other
histologic characteristics of the vulnerable lesion (18). In
addition, their activity is enhanced in aortic aneurysms (24).
By release of MMPs, macrophages initiate the degradation
of fibrillar collagen that forms the skeleton of the fibrous
cap.
TECHNIQUES CHARACTERIZING THE
ATHEROSCLEROTIC VULNERABLE PLAQUE
Choice, guidance and evaluation of an intervention tech-
nique are currently based on the routinely used visualization
techniques like angiography and intravascular ultrasound.
New diagnostic modalities may contribute to the under-
standing of the mechanisms underlying progression of
atherosclerotic disease and plaque rupture, and lead to
potential new therapeutic approaches aimed at the acute
complications of atherosclerotic disease. Not only the de-
gree of luminal stenosis but also the composition of the
atherosclerotic plaque may determine the decision of which
intervention type to use.
Most visualizing techniques that will be mentioned in
this article are catheter based. Catheter-based techniques
visualize the atherosclerotic plaque locally, which may limit
clinical applicability, since it would be impractical and too
time consuming to visualize all lesions in all coronary
arteries. In addition, it should be critically appreciated that
it is still unclear how clinical decision making will be
influenced by these plaque characterization techniques,
since etiologic research on the mechanism of plaque rupture
and on the predictive values of a thin cap or a large atheroma
for a plaque to rupture is lacking.
High-frequency (20 to 40 MHz) intravascular ultra-
sound. Intravascular ultrasound (IVUS) is a catheter-based
imaging technique that provides two-dimensional cross-
Abbreviations and Acronyms
IVUS 5 intravascular ultrasound
MMP 5 matrix metalloproteinase
MRI 5 magnetic resonance imaging
OCT 5 optical coherence tomography
Figure 1. Picro Sirius staining for collagen of atherosclerotic cross-
sections. (A) Atherosclerotic plaque with a fibrous cap overlying lipid-rich
areas. Thickness of the cap near the arrows is approximately 400 mm. (B)
Atherosclerotic plaque with the atheroma adjacent to the lumen due to
rupture of the thin fibrous cap. Thickness of the fibrous cap near the
rupture (black arrows) is approximately 300 mm. (C) Rupture of the
fibrous cap (black arrow).
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sectional tomographic images of the arterial wall (25). In
vitro and in vivo studies have demonstrated the accuracy and
reproducibility to assess quantitatively lumen area, plaque
area and vessel area as well as morphologic features like
calcifications and, after balloon angioplasty, the presence of
dissections (25,26). Currently, IVUS is the only imaging
modality that provides images in which variations in arterial
geometry and atherosclerotic plaque along the artery can be
studied in vivo (27–29).
The resolution of the ultrasound system is related to its
frequency. Axial resolution is approximately 100 mm to
200 mm for 40-MHz and 20-MHz systems, respectively.
Lateral resolution varies widely dependent on the beam
width that is used but approximates 250 mm for 30 MHz.
The penetration depth is inversely related to the frequency
and is approximately 10 mm for a 30-MHz system. For
high-frequency (40 to 50 MHz) systems, imaging may be
hampered by an increased backscatter of blood.
Lipid-rich areas tend to appear as echolucent in the still
frame IVUS image (25,30). However, the echo-lucency of
these lipid lakes may depend on surrounding tissues (31).
Histopathologic studies mostly report low sensitivities for
IVUS in detecting lipid-rich lesions (30). A recent study,
however, reports that the thickness of the fibrous cap and
fractures with lipids protruding into the lumen were visu-
alized (32), but no histologic validation was given. Only
systems using frequencies of $40 MHz may allow reliable
detection of thin fibrous caps, considering that the cap
thickness in which circumferential stresses become critical
may be ,150 mm (14).
There are consistent reports on the association of calci-
fications and unstable syndromes: calcifications as observed
in the IVUS image are more commonly observed in stable
than in unstable syndromes (33,34).
Recent postmortem (35) and ultrasound studies (36–38)
showed an intriguing relation between locally altered vessel
size and histopathologic and clinical markers for plaque
vulnerability. Thus, local arterial vessel size as measured
with IVUS may be an indicator for lesion stability. Whether
the mode of arterial remodeling and plaque vulnerability are
related or associated remains to be investigated.
IVUS elastography. Ultrasound elastography is a new
method to assess mechanical properties of parts of the
atherosclerotic plaque (39–41). Tissue components that
differ in hardness are expected to be compressed differently
if a defined pressure is applied. As the response of tissue to
mechanical excitation is a function of its mechanical prop-
erties, hard tissues (calcifications and collagen) will be
compressed less than soft-tissue types (lipids) (39). From
the radiofrequency data of two ultrasound images that have
been obtained in a diastolic and systolic part of the heart
cycle, strain images are constructed using the relative local
displacements, which are estimated from the time shifts
between gated echo-signals acquired. Hard and soft regions
can be identified using this technique, while in the original
image, it is not possible to discriminate the different tissue
types (39). Recently, in vitro validation studies have been
performed that demonstrated that elastography is capable of
discriminating lipid-rich regions from fibrous regions
within atherosclerotic cross-sections (40,41) (Fig. 2). The
major advantage of the elastography technique is that it
makes use of the radiofrequency data of the regular IVUS
systems, which makes the introduction of another catheter
redundant.
Angioscopy. Angioscopy allows visualization of the plaque
with high sensitivity. Owing to its color detection quality,
thrombus is detected with high sensitivity (42). Plaque color
on angioscopy is found to be closely related to clinical
syndrome: yellow plaques are lipid rich and often associated
with acute coronary syndromes (43,44). In addition, angio-
scopic identification of plaque rupture and subsequent
thrombosis at the culprit lesions after catheter-based inter-
ventions is related to adverse outcomes (45). Angioscopic
studies have improved the understanding of the mechanism
of thrombolytic therapy after myocardial infarction when
dissolving of the thrombus was visualized (46).
Still, the inability to examine the different layers within
the arterial wall remains. Thus, no estimation of cap
thickness or lipid content can be made making morphologic
characterization of the plaque unreliable.
Magnetic resonance imaging. Magnetic resonance imag-
ing (MRI) can be used to discriminate luminal boundaries
by visualizing the blood flow. Magnetic resonance imaging
studies are currently being performed to study the progres-
sion and regression of atherosclerotic plaques over time.
High-resolution fast spin echo and optimized computer
processing have enhanced the spatial resolution (0.4 mm) of
visualizing atherosclerotic plaques in vivo. In experimental
studies, the atherosclerotic lesions have been studied in
hypercholesterolemic rabbits (47), pigs (48) and nonhuman
primates (49). In genetically engineered mice, an excellent
agreement was observed between high-resolution MRI (9T
system, in plane spatial resolution 97 mm) and histopathol-
ogy and demonstrated that in small animal models this
technique can be used to monitor the development of
atherosclerotic pathology over time and the response to
therapy (50) (Fig. 3). In humans with carotid atherosclero-
sis, MRI was among the first noninvasive imaging tech-
niques that allowed discrimination of lipid and fibrous
tissues (51).
Theoretically, MRI is a promising noninvasive tool for
detecting vulnerable plaques. At present, however,
whole-body MRI at 1.5T lacks sufficient resolution
(currently 400 mm) for accurate measurements of cap
thickness and characterization of the atherosclerotic le-
sion within the coronary circulation. To improve the
signal-to-noise ratio, an intravascular catheter coil has
been developed that enhances image resolution to 250 to
300 mm. This intravascular MRI technique shows an 80%
agreement with histopathology in analysis of intimal
thickness and accurately determines plaque size (52).
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However, this resolution would still be too limited to
determine cap thickness accurately. More recent studies
have reported in-plane resolutions of 117 3 156 mm (53)
for high-resolution intravascular MRI imaging, which is
comparable to resolutions as obtained with IVUS. Thus,
although difficulties remain with in vivo imaging, it may
be a matter of time before MRI is used for identification
of vulnerable plaques in human coronary artery disease.
Figure 2. Echogram (upper panel, left), elastogram (upper panel, right) and histologic sections with alfa actin stain (left bottom panel), and picro Sirius
red stain without (bottom middle panel) and with polarized light (bottom right panel) of a human femoral artery. The echogram reveals an eccentric
plaque between the 2 and 11 o’clock position. The elastogram shows that the plaque can be divided into two parts: a low strain part (0.2%) between the
4 and 11 o’clock position and a high strain part (1.0%) between the 2 and 4 o’clock position, both compared to the moderate strain (0.5%) in the normal
vessel wall. Histologic study reveals that the region between the 4 and 11 o’clock position is fibrous material and the region between the 2 and 4 o’clock
position lacks smooth muscle cells (white arrow, left bottom panel) and collagen (white arrow right bottom panel) (with courtesy of C de Korte and T van
der Steen, Erasmus University, Rotterdam).
Figure 3. Magnetic resonance imaging of abdominal aorta (arrow) in normal mouse and apoE-KO mouse showing differences between normal and
atherosclerotic arteries. On all MRIs, lumen is dark. Normal abdominal aorta wall thickness is approximately 50 mm and was not clearly visible at spatial
in plane resolution of 97 mm. Wild-type mice were free of atherosclerotic lesions as shown on MRIs in A and B and histopathology (C). Large
atherosclerotic lesion (arrow) that encircles the abdominal aorta of an apoE-KO mouse is shown on the MRI in D and E and was confirmed by
histopathologic study (F). All MRIs have pixel size of 97 3 97 3 500 mm3 (adapted from Fayad et al [50]).
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Nuclear scintigraphic imaging techniques. Scintigraphy
is based on the specific binding of radioactive labeled
molecules to the target tissue, in this case the atherosclerotic
rupture-prone lesion. According to Vallabhajosula and Fus-
ter (54), the ideal radiotracer for visualizing the vulnerable
plaque should meet the following criteria:
1) it must be specific for lipid core, macrophage density or
thrombus;
2) it must be able to detect lesions in all atherosclerotic
artery types that are related to clinical symptoms;
3) it must be able to assess progression-regression of
atherosclerosis;
4) it must be able to predict clinically significant events;
5) it must be able to provide prognostic indicators in
population studies; and
6) it must have a kit formulation for instant preparation,
high specificity and sensitivity, fast blood clearance and
high lesion to blood ratios.
There are no single radiotracers that meet all these criteria.
In vivo studies have been performed using radiolabeled
low-density lipoprotein which accumulates in the athero-
sclerotic plaque (55). Another in vivo tested label is IgG
immunoglobulin which recognizes most atherosclerotic le-
sions but which is not specific for certain advanced stages of
atherosclerotic disease (56,57). Circumventing the problem
of nonspecific localization of IgG, a mouse/human chimer-
ical monoclonal IgM antibody fragment with specificity for
an antigen associated with proliferating smooth muscle cells
has been studied in human atheroma (58). These aforemen-
tioned radiotracers, however, are not specifically related to
rupture-prone plaques. Radiolabeled peptides incorporated
specifically in mural thrombi may prove to be more clinically
applicable (59,60).
Thermometry. Hypothetically, temperature measurements
can be used to detect local inflammatory processes in the
arterial wall. The thermistor is capable of measuring tem-
peratures superficially with an accuracy of #0.1°C. Casscells
et al. (61) showed in a freshly obtained carotid endarterec-
tomy specimen a temperature rise up to 2.2°C in
macrophage-rich areas. In that study, a significant correla-
tion was observed between macrophage density and local
temperature. More recently, the first study on in vivo
assessment of local thermal heterogeneity in the coronary
artery has been reported. Stefanadis et al. (62) recently
reported temperature differences in the arterial wall in vivo
using a thermistor on a 3F catheter with a 0.05°C accuracy
and a spatial resolution of 500 mm. In a study of 90 patients,
they observed higher temperatures of the coronary arterial
wall in lesions of patients suffering from unstable angina and
myocardial infarction compared with lesions studied in
patients with stable angina (62).
Optical Coherence Tomography (OCT). Optical coher-
ence tomography has been successfully applied as an imag-
ing tool in ophthalmology (63) and is now being investi-
gated for its potential as an intravascular imaging device
(64). The principle of OCT is similar to that of ultrasound
imaging. A beam of low coherent infrared laserlight rather
than sound is directed and reflected within the tissue.
Intravascular OCT catheters have been developed and
applied in animal experiments in vivo. The intravascular
device is capable of visualizing the atherosclerotic lesion
with an axial resolution of 2 to 30 mm depending on the
spectral width of the source and a lateral resolution of 5 to
30 mm determined by the beam waist (Fig. 4). The current
penetration depth is limited to 1 to 2 mm. A trade-off exists
between resolution and the penetration depth. In vitro
validation studies revealed that OCT is capable of differen-
tiating lipid tissue from water-based tissues (64). In addi-
tion, the thickness of the fibrous cap overlying an atheroma
can be demarcated by OCT (64). Compared with IVUS,
OCT provides a sharper delineation between intimal wall
and plaque with collections of lipid (65).
Because of its high resolution and the fact that this
technique can be easily incorporated into a thin catheter,
OCT is a promising imaging modality for plaque charac-
terization, although successful clinical application of the
OCT may be hampered by the low penetration depth and
the absorbance of light by blood.
Raman spectroscopy. Raman spectroscopy may be consid-
ered the acquisition of a molecular fingerprint. This char-
acteristic makes Raman spectroscopy ideal for identifying
gross chemical changes in tissue, such as in atherosclerosis
(66). Raman spectra are collected as follows: light of a single
wavelength from a laser is directed onto the tissue sample
via glass fibers. Light scattered from the sample is collected
in fibers and launched into a spectrometer. The plot of
signal intensity as a function of wavelength (or frequency)
can be obtained in a few seconds (67). To extract clinically
useful information from these spectra, spectral modeling is
performed (68,69). In vitro studies have demonstrated that
diagnostic algorithms allow the discrimination of coronary
arterial tissue in three categories: nonatherosclerotic, non-
calcified plaque and calcified plaque (68).
Figure 4. Optical coherence tomography image of a longitudinal cross-
section of a nonatherosclerotic coronary artery. Top panel: elastin von
Gieson staining of the artery of which the lumen is collapsed. M 5 media,
A 5 adventitia. Bottom panel: the corresponding OCT image (scale is in
centimeters) (with courtesy of T van Leeuwen and J Perree, Academic
Medical Center, Amsterdam).
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Penetration depth of the Raman spectroscopy in arterial
tissue is reported to be 1.0 to 1.5 mm. This would allow the
Raman technique to examine tissue types beneath fibrous
caps and within the atheromatous core. If one properly
accounts for the depth of a cholesterol deposit into an
arterial wall, it has been shown that cholesterol amounts
calculated with spectra correlate strongly to amounts deter-
mined with quantitative microscopy (70).
Current limitations of Raman spectroscopy are the strong
background fluorescence and the absorbance by blood of the
laser light. In addition, information on plaque configuration
is lost. The combination of Raman spectroscopy with IVUS
or OCT into one catheter may be attractive since informa-
tion on the chemical composition and tomography of the
plaque would be obtained simultaneously (Fig. 5).
Thus, intravascular Raman spectroscopy is an imaging
modality in an early stage of development that has great
potential to discriminate in vivo among lipid-rich, calcified
and fibrotic plaques.
The aforementioned techniques are just a selection of the
imaging modalities currently used in vivo or that are in a
validation stage. Electron-beam CT is a noninvasive detec-
tion method if calcifications are considered a surrogate end
point of clinically relevant coronary artery disease. However,
even with people who have a family history of heart disease,
other risk factors tend to predict cardiac events better than
the calcium score (71). In addition, positron emission
tomographic scan has been mentioned as a method to
identify inflammatory regions (61). Finally, in animal and
postmortem validation studies, near-infrared spectroscopy
(72), time-resolved laser-induced fluorescence spectroscopy
(73) and electrical impedance measurements (74,75) were
able to detect plaques with a thin cap and a large lipid pool
with high sensitivity.
PLAQUE “IMAGING” MODALITIES:
A ROLE IN CLINICAL DECISION
MAKING OR EXPERIMENTAL TOY?
Most techniques mentioned in this article have the potential
to locally detect one or more of the three determinants
(atheroma, cap thickness and inflammation) of the vulner-
able plaque. Most techniques specifically address the char-
acterization of plaque content (IVUS, MRI, Raman, im-
pedance). Optical coherence tomography is the only
modality that has the resolution to focus on cap thickness,
whereas elastography uses local compression as a surrogate
for cap thickness and plaque composition. Local tempera-
ture is thus far the only measure of inflammation within the
arterial wall. Except for MRI and scintigraphy, all visual-
Figure 5. Intravascular ultrasound image of a calcified coronary artery (left), and the relative weights of calcium salts (top) and total cholesterol (bottom)
in the same artery plane determined by Raman spectroscopy. The IVUS images were obtained from an intact artery segment, which were marked by a needle
(12 o’clock). Raman spectra were obtained from the artery after the artery was opened. The IVUS image shows a calcification, in agreement with the calcium
salts detected with Raman spectroscopy. Cholesterol was detected with Raman spectroscopy but could not be discriminated within the IVUS image (with
courtesy of R Buschman and TJ Ro¨mer, Leiden University Medical Center).
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ization techniques require invasive intravascular catheter
intervention.
For the clinician, the question is: what do these tech-
niques contribute to the understanding (etiology), diagnosis
and treatment/prevention of coronary artery disease?
Before a modality that aims to characterize the vulnerable
plaque will have diagnostic or prognostic value, several
hurdles need to be taken.
First, validation of the imaged features like cap thickness,
plaque type and inflammation on a histologic resolution
level is obligatory. Interpretations of imaged features like a
“lipid lake” or a “fibrous cap” must not only be based on the
priori knowledge of the expected localization of that feature
within the image but also on histology like validation.
Secondly, the modality should be made safely applicable for
in vivo studies, preferably for the coronary circulation.
Thirdly, the predictive value of the vulnerable plaque
determinants for a plaque to rupture needs to be investi-
gated first. Until now, to our knowledge, no studies have
been performed on the predictive value of each of the three
markers for a plaque to rupture (e.g., inflammation, large
atheroma and thin fibrous cap). This third hurdle brings up
another question which may result in a vicious circle: how is
plaque rupture assessed retrospectively? Thus, the fourth
hurdle is to find a diagnostic measure of plaque rupture. It
will not be feasible to determine the occurrence of plaque
rupture on a tissue level in a large clinical study. Therefore,
surrogate end points must be searched for, like rapid
acceleration of luminal narrowing on angiography or IVUS.
Finally, in a prospective study, the determinants of plaque
rupture should be related to the incidence of acute events,
taking into account the role of collateral circulation.
It is not likely, however, that a high predictive value of
one of the visualized markers for plaque rupture will
subsequently implicate a high diagnostic or prognostic value
for the occurrence of a clinical event for two reasons. First,
most visualization techniques will provide insight into
components of the atherosclerotic plaque locally. It is
reasonable to expect that visualization techniques will be
guided toward lesions of angiographic interest and thus
toward hemodynamically significant lesions. However, since
lumen size is not related to local plaque vulnerability
(5–7,35) only visualization of all atherosclerotic lesions
throughout the entire coronary tract will provide insight
into the “vulnerable state” of the major coronary branches. It
is not practical to catheterize all coronary arteries and
characterize all lesions. Secondly, inflammation and proba-
bly also other markers for plaque vulnerability are frequently
and commonly observed features throughout the coronary
arterial system (76). It is therefore unlikely that presence of
a vulnerability marker has a high prognostic value for the
occurrence of a clinically significant plaque rupture. The
prognostic value of either a large atheroma or a thin fibrous
cap is also impaired by the fact that part of the acute cardiac
events are caused by local erosion of the plaque rather than
rupture (9). Thus, although in the future catheter-based
visualization techniques might allow vulnerability character-
ization of individual lesions, they may not provide prognos-
tic estimates for the occurrence of a clinical event.
Techniques that allow detection of the three histologic
markers for vulnerable plaques locally will certainly contrib-
ute to the understanding of serial events occurring in
atherosclerotic disease by elucidating the predictive value of
each of the potential markers for a plaque to rupture.
However, local plaque composition may change over time
with alteration of biochemical, dietary or environmental
influences. A static measurement may therefore still have
limited predictive value for local plaque rupture.
Techniques that are capable of characterizing the deter-
minants related to plaque vulnerability may also contribute
to the understanding of how pharmacological treatment,
like, for example, statins, improve clinical outcome. The
techniques are likely to further elucidate the effects of
treatment on inflammation, reduction of atheromatous
plaque mass, endothelial function or improved geometric
remodeling (77–79).
The aforementioned described imaging techniques aim
on visualizing the vulnerable rupture prone plaque locally.
With most of these techniques intravascular catheter inter-
vention is inevitable. It is less invasive to collect blood
samples and determine systemic markers that are considered
a surrogate end point for plaque vulnerability (80,81).
However, since a clinical event is due to a local obstruction
of the lumen and considering that plaque rupture may be a
common feature in atherosclerotic disease, it is hard to
understand how a systemic value of a marker for inflamma-
tion can be an accurate predictor for the occurrence of a
locally determined clinical event. A systemically determined
marker may be considered as a surrogate end point for the
vulnerable state of atherosclerotic plaques throughout the
circulation. The occurrence of a clinical event, then, is a
matter of chance: the more vulnerable lesions are present
throughout the coronary circulation, the more plaques may
rupture with subsequent thrombotic occlusion of the lumen.
Thus, where local imaging techniques may help understand
the etiology of atherosclerotic luminal narrowing locally,
systemic markers seem to have more potential when it
comes to identification and prognosis of the patient with
rupture-prone plaques.
CONCLUSION
Imaging modalities that aim to detect the vulnerable,
rupture-prone lesion primarily focus on three postmortem
observed determinants that have been identified in ruptured
plaques: thickness of the fibrous cap, the extent of the
atheromatous core and local inflammation. The highest
resolutions are achieved by catheter-based techniques. Ex-
cept for OCT, however, the resolution of current techniques
is still too limited to discriminate the thin fibrous cap. The
noninvasive imaging modalities like MRI suffer from inad-
equate resolutions, but their unlimited penetration depth
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and noninvasive nature are advantages. Imaging techniques
that visualize the plaque locally may provide new insight
into the etiology of sudden progression of atherosclerotic
disease or acute events. However, due to their local appli-
cability, it is not expected that they will have prognostic
properties for the development of acute clinical syndromes
that often originate from nonhemodynamically significant
lesions. Therefore, systemic markers for inflammation may
have more prognostic value for the identification of patients
suffering from clinical events as a result of plaque rupture.
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